Dry Eye Syndromes: all 1,325 studies

Page 5 of 14. Open to participants first (193), then studies with results posted, then the rest; newest registration first within each.

• Clinical Evaluation of Systane® Gel Drops in Dry Eye SubjectsCompletedNCT02380248Not applicableResults posted
• LME636 in the Relief of Persistent Ocular Discomfort in Subjects With Severe Dry Eye DiseaseCompletedNCT02365519Phase 2Results posted
• Evaluation of the Safety and Effectiveness of the Oculeve Intranasal Lacrimal Neurostimulator in Patients With Dry EyeCompletedNCT02313454Not applicableResults posted
• A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)CompletedNCT02284516Phase 3Results posted
• A Safety and Efficacy Study of Refresh Optive® Gel Drops in Patients With Dry Eye DiseaseCompletedNCT02280473Phase 3Results posted
• Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry EyeCompletedNCT02257957Phase 3Results posted
• Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis SiccaCompletedNCT02254265Phase 2/3Results posted
• Prevalence of Dry Eye Disease in Patients Diagnosed With Rheumatoid ArthritisCompletedNCT02252744Results posted
• The Effects of Cyclosporin A in a Low Humidity Environment, on the Ocular SurfaceTerminatedNCT02199964Not applicableResults posted
• DNase Treatment for Dry EyesTerminatedNCT02193490Phase 1/2Results posted
• Safety and Efficacy of KPI-121 in Subjects With Dry Eye DiseaseCompletedNCT02188160Phase 2Results posted
• Dry Eye Assessment and Management StudyCompletedNCT02128763Phase 3Results posted
• Investigation of Maintaining Visual Performance Achieved With Cyclosporine TherapyCompletedNCT02121847Phase 4Results posted
• A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)CompletedNCT02121301Phase 2Results posted
• The Utility of IVCM to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With DEDCompletedNCT02120079Phase 4Results posted
• A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry EyeCompletedNCT02117687Phase 4Results posted
• Treatment of Meibomian Gland Dysfunction and Dry Eye in Contact Lens WearersCompletedNCT02102464Not applicableResults posted
• Safety and Efficacy of rhNGF Eye Drops at Different Doses in Patients With Dry EyeCompletedNCT02101281Phase 2Results posted
• Laser Therapy to Treat the Dry Mouth of Sjogren's SyndromeCompletedNCT02066896Not applicableResults posted
• IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHDCompletedNCT02066051Not applicableResults posted
• A Study of Sodium Carboxymethylcellulose for Post Cataract Surgery Dry Eye SymptomsCompletedNCT02028754Phase 4Results posted
• Efficacy and Safety of T2762 and Vismed® in Dry Eye SyndromeCompletedNCT02023268Phase 3Results posted
• Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye DiseaseTerminatedNCT02013791Phase 2Results posted
• Clinical Outcomes Following Treatment With Systane® Balance in Dry Eye SubjectsCompletedNCT01967147Not applicableResults posted
• The Retention Rate Between Brand A and Brand B Punctal PlugsCompletedNCT01947517Results posted
• A Study to Determine the Prevalence of Inflammatory Dry Eye Disease in Patients Prior to Cataract RemovalCompletedNCT01882413Results posted
• Clinical Evaluation of Systane® ULTRA Compared to OPTIVE® in Ocular Surface StainingCompletedNCT01863368Not applicableResults posted
• An Observational Study of Dry Eye Prior to Laser-Assisted in Situ Keratomileusis (LASIK) TherapyCompletedNCT01854905Results posted
• Efficacy and Safety Study of FID 119515ACompletedNCT01833117Not applicableResults posted
• Impairment of Reading Ability in Dry Eye PatientsCompletedNCT01826812Results posted
• Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)CompletedNCT01817582Phase 2Results posted
• Treatment of Meibomian Gland Dysfunction Prior to Cataract SurgeryCompletedNCT01808560Not applicableResults posted
• Effects of Dry Eye Treatments on the Ocular SurfaceCompletedNCT01797822Phase 4Results posted
• A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry EyeCompletedNCT01743729Phase 3Results posted
• SYSTANE® Family - Meibomian DeficiencyCompletedNCT01733745Not applicableResults posted
• SYSTANE® BALANCE Symptoms (OSDI) & Inflammatory BiomarkersCompletedNCT01733732Not applicableResults posted
• The Effect of SYSTANE® BALANCE on Tear Film Break Up Time in Dry Eye SubjectsCompletedNCT01718028Not applicableResults posted
• An Observational Study of OPTIVE PLUS® for the Treatment of Dry Eye DiseaseCompletedNCT01711424Results posted
• Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol Etabonate 0.5%CompletedNCT01695668Not applicableResults posted
• Evaluation of SYSTANE® BALANCE in Dry Eye Subjects With Lipid DeficiencyCompletedNCT01688726Not applicableResults posted
• Safety and Efficacy of Punctal Plug Insertion in Patients With Dry EyeCompletedNCT01684436Phase 4Results posted
• Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma PatientsCompletedNCT01682460Phase 4Results posted
• A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye DiseaseCompletedNCT01664949Phase 3Results posted
• Confirmatory Study of OPC-12759 Ophthalmic SolutionCompletedNCT01660256Phase 3Results posted
• Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry EyeCompletedNCT01657253Phase 3Results posted
• Evaluation of Ocular Comfort With ISTA Tears vs SystaneCompletedNCT01650584Not applicableResults posted
• Safety Study of Lifitegrast to Treat Dry EyeCompletedNCT01636206Phase 3Results posted
• Tear Osmolarity Changes After Instilling Isotonic Hyaluronate Artificial TearsCompletedNCT01614847Phase 4Results posted
• Clinical Evaluation of a Daily Disposable Contact Lens in Symptomatic Weekly/Monthly Lens WearersCompletedNCT01614600Not applicableResults posted
• Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye SyndromeCompletedNCT01568593Phase 3Results posted
• Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye SyndromeCompletedNCT01541891Phase 2Results posted
• Randomized Controlled Trial of Long-term Treatment Effectiveness for Meibomian Gland Dysfunction (MGD) and Dry EyeCompletedNCT01521507Not applicableResults posted
• Effect of Contact Lenses on Tear Osmolarity in a Controlled Low Humidity ChamberCompletedNCT01482312Not applicableResults posted
• Safety Study of OPC-12759 Ophthalmic SolutionCompletedNCT01471093Phase 1Results posted
• Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye DiseaseCompletedNCT01459588Phase 3Results posted
• Prevalence of Dry Eyes in Diabetics Compared to Non DiabeticsTerminatedNCT01450787Results posted
• Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1)CompletedNCT01421498Phase 3Results posted
• Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry EyeCompletedNCT01393132Phase 2Results posted
• Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry EyeCompletedNCT01387347Phase 2Results posted
• Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye SyndromeCompletedNCT01382225Phase 3Results posted
• Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye SufferersCompletedNCT01339936Phase 2/3Results posted
• ESBA105 in Patients With Severe Dry EyeCompletedNCT01338610Phase 2Results posted
• Study of Two Formulations of Cyclosporine Ophthalmic Emulsion in Healthy Volunteers and in Patients With Dry EyeCompletedNCT01319773Phase 1Results posted
• Tear Evaluation Between Habitual Contact Lens Wearers and Non Contact Lens WearersTerminatedNCT01317030Results posted
• RPS InflammaDry Detector™ to Determine MMP-9 Levels in TearsCompletedNCT01313351Results posted
• Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye DiseaseCompletedNCT01294384Phase 3Results posted
• The Effects of BAK on the Blood Aqueous Barrier of Pseudophakic PatientsCompletedNCT01280110Phase 4Results posted
• Evaluation of Anti-Inflammatory Treatment in Dry Eye PatientsCompletedNCT01276223Phase 2Results posted
• Study to Evaluate a Contact Lens Lubricating and Rewetting DropCompletedNCT01267656Not applicableResults posted
• The Effects of a Single Intravenous Administration of Secukinumab (AIN457) or Canakinumab (ACZ885) in Dry Eye PatientsCompletedNCT01250171Phase 2Results posted
• Phase III Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry EyeCompletedNCT01240382Phase 3Results posted
• Trial of CF101 to Treat Patients With Dry Eye DiseaseCompletedNCT01235234Phase 3Results posted
• Non-invasive Ocular Surface Measurements Before and After InterventionsTerminatedNCT01228929Not applicableResults posted
• A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye DiseaseCompletedNCT01212471Phase 3Results posted
• Evaluation of Screening Methods for Treatment of Meibomian Gland DysfunctionCompletedNCT01202747Phase 2/3Results posted
• Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry EyeCompletedNCT01189032Phase 2Results posted
• Study to Assess the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye SyndromeCompletedNCT01163643Phase 2Results posted
• Effects of Cataract Extraction Surgery and Limbal Relaxing Incision on Corneal Sensation and Dry EyeCompletedNCT01161771Results posted
• A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye DiseaseCompletedNCT01135511Phase 2Results posted
• Non-invasive Tear Film Dynamic Measurements in Normal, MGD and ADDE Subjects After Saline InstillationCompletedNCT01128049Not applicableResults posted
• Oral Omega-3 Fatty Acids in the Treatment of Dry Eye SyndromeCompletedNCT01107964Not applicableResults posted
• Dry Eye Assessment and Management: Feasibility StudyCompletedNCT01102257Phase 2/3Results posted
• Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye DiseaseTerminatedNCT01072526Phase 2Results posted
• The Effect of a New Emulsion in Dry Eye Patients on Tear Layer Aberrometry, Contrast Sensitivity, and Reading AbilityCompletedNCT01013077Not applicableResults posted
• Safety and Efficacy of Two Artificial Tears in Dry Eye SubjectsCompletedNCT01010282Not applicableResults posted
• Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry EyeCompletedNCT00987727Phase 4Results posted
• Acupuncture for Dry Eye SyndromeCompletedNCT00969280Phase 3Results posted
• Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and SymptomsCompletedNCT00938704Phase 4Results posted
• Safety and Tolerability of Artificial Tears in Dry Eye SubjectsCompletedNCT00932477Not applicableResults posted
• A Study Evaluating the Efficacy of SAR 1118 (0.1%, 1.0%, 5.0%) Ophthalmic Solution in Subjects With Dry Eye Conducted in a Controlled Adverse Environment (CAE)CompletedNCT00926185Phase 2Results posted
• Efficacy, Tolerability, and Comfort of 0.3% Hypromellose Eyedrops in Patients Undergoing LASIK SurgeryCompletedNCT00909324Phase 4Results posted
• Confirmatory Study of OPC-12759 Ophthalmic SuspensionCompletedNCT00885079Phase 3Results posted
• Keratometric Tear Breakup Time and Fluorescein Tear Breakup TimeCompletedNCT00854906Results posted
• TearLab Core Validation Study to Establish Referent Values for Dry Eye DiseaseCompletedNCT00848198Results posted
• Treatment of Meibomian Gland Dysfunction and Evaporative Dry EyeCompletedNCT00832130Not applicableResults posted
• Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%CompletedNCT00827255Results posted
• Long Term Administration Study of OPC-12759 Ophthalmic SuspensionCompletedNCT00818324Phase 3Results posted
• A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye.CompletedNCT00784719Phase 1/2Results posted
• Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye SymptomsCompletedNCT00761202Phase 4Results posted
• Safety and Efficacy of an Ophthalmic Solution in Dry Eye DiseaseCompletedNCT00758784Phase 2Results posted

← Dry Eye Syndromes overview